• Skip to main content
  • Skip to footer

Amicus

  • Home
  • About Fabry
    • Fabry disease pathophysiology and natural history
    • Prevalence of Fabry disease
    • GLA gene mutations and inheritance
    • Clinical manifestations of Fabry disease
    • Diagnosis of Fabry disease
    • Management of Fabry disease
  • About Pompe
    • Pompe disease pathophysiology and natural history
    • Prevalence of Pompe disease
    • GAA gene mutations and inheritance
    • Clinical manifestations of Pompe disease
    • Diagnosis of Pompe disease
    • Management of Pompe disease
  • Your Specialty
    • Nephrology
      • Renal pathophysiology in Fabry disease
      • When should a nephrologist suspect Fabry disease
      • Management of Fabry disease
    • Cardiology
      • Cardiac pathophysiology in Fabry disease
      • When should a cardiologist suspect Fabry disease
      • Management of Fabry disease
    • Neuropsychology and ophthalmology
      • Pathophysiology and progression in Fabry disease
      • Neurology and Fabry disease
      • Psychology and Fabry disease
      • Ophthalmology and Fabry disease
      • When should you suspect Fabry disease?
      • Management of Fabry disease
    • Respiratory
      • Respiratory pathophysiology in Pompe disease
      • When should a respiratory specialist suspect Pompe disease?
      • Management of Pompe disease
    • Neurology
      • Pathophysiology of muscle damage
      • When should a neurologist suspect Pompe disease?  
      • Management of Pompe disease
  • Resources
    • All Resources
    • Latest Blog
  • Find a specialist centre

This non-promotional website is intended for UK Healthcare Professionals only.

About Amicus Therapeutics

Amicus Therapeutics is a global, patient-dedicated biotechnology company focused on discovering, developing and delivering high-quality medicines for people living with rare metabolic diseases.

Amicus Therapeutics is committed to providing quality medical education. The Amicus Education website has been developed to help UK healthcare professionals increase their knowledge of specific rare metabolic diseases, enabling them to support their patients. For more information please visit the company’s website at www.amicusrx.co.uk.

NP-NN-UKI-00221024
October 2024

Footer

Amicus is committed to providing medical education for UK healthcare professionals. This website is a non-promotional site developed and funded by Amicus.

Menu
Home
About Fabry
About Pompe
Nephrology
Cardiology
Neuropsychology and Ophthalmology
Respiratory
Neurology
Resources
Find a Specialist Centre

Company
About Amicus

Help
Contact us

© Amicus Education 2024. All rights reserved | Amicus therapeutics UK LTD One Globeside, Fieldhouse Lane, Marlow SL7 7HZ United Kingdom | Company registration no. 05541527 | NP-NN-UKI-00090325 March 2025 Privacy policy | Cookie policy | Terms of use